investing

Analysts Raymond James upgraded Advanced Micro Devices (AMD) to Strong Buy and raised target price to $641, expecting 40% upside

08/25/2026, 04:37 AM investing rating_growth Analysts: analysts, Raymond James semiconductors Advanced Micro Devices

Raymond James has upgraded Advanced Micro Devices (AMD) to a strong buy, predicting it will surpass Intel in the CPU market by 2027, which could significantly enhance AMD's stock appeal.

Market Movers: Anticipation Builds Ahead of Nvidia’s Earnings Report and Insights on Data Center Stocks

08/24/2026, 04:37 PM investing review Micron General Electric BMO Financial Group Expedia Group Nvidia Dick's Sporting Goods Amgen

Investors should pay attention to upcoming earnings reports from Nvidia and Dick's Sporting Goods, as well as trends in the data center sector, which could influence stock performance significantly.

Analysts Deutsche Bank expect gold prices to rise following Treasury bond market intervention

08/24/2026, 01:37 PM investing forecast Analysts: analysts, Deutsche Bank finance Deutsche Bank

Deutsche Bank analysts predict that the U.S. Treasury's plan to increase bond buybacks could push gold prices significantly higher, potentially exceeding $4,800 an ounce. This development highlights the growing influence of government policy on gold as a safe-haven asset amid market volatility.

ClearBridge Investments' Michael Clarfeld Highlights 'Overlooked Gems' Offering Attractive Dividends Amid Market Volatility

08/24/2026, 12:38 PM investing research finance consumer ADP Williams Companies Unilever

Michael Clarfeld from ClearBridge Investments highlights overlooked stocks that offer attractive dividends amidst a volatile market dominated by technology companies. He emphasizes the importance of diversification and identifies specific companies that present solid investment opportunities.

Analysts Needham and 22V Research highlight potential for further gains in Bitcoin (BTC) following significant three-day rally

08/24/2026, 11:37 AM investing forecast Analysts: analysts, Needham finance

Analysts suggest that Bitcoin's recent 22% surge may indicate a more sustained recovery, driven by a combination of macroeconomic factors and a significant short squeeze, positioning the cryptocurrency favorably for future gains.

Analysts Fairlead Strategies highlight Nutrien Ltd. (NTR) emerging from a corrective phase with bullish momentum

08/24/2026, 10:38 AM investing research Analysts: analysts finance consumer Nutrien

Agribusiness stocks are gaining traction as the VanEck Agribusiness ETF (MOO) and Nutrien Ltd. (NTR) show signs of a bullish trend, indicating potential for further gains in the sector.

Goldman Sachs Reports 29% Year-to-Date Return for Portfolio of Favorite Stocks, Adding New Members

08/24/2026, 10:38 AM investing review finance SpaceX Capital One Boeing Thermo Fisher Scientific Mastercard Visa

Goldman Sachs identified six stocks favored by both hedge funds and mutual funds, highlighting a significant shift towards financial stocks, which could indicate broader market trends and investment strategies.

Massive Trade in SPDR Gold Shares (GLD) Signals Potential Bearish Outlook for Gold

08/24/2026, 10:38 AM investing forecast finance materials SPDR Gold Shares

Gold prices have surged 15% this month, but a significant options trade suggests a potential downturn ahead, which could impact investor sentiment and market dynamics.

Analysts recommend buying SPDR S&P 500 ETF Trust (SPY) call options amid market volatility and Nvidia earnings report

08/24/2026, 09:38 AM investing recommendation Analysts: analysts finance semiconductors SPDR S&P 500 ETF Trust Nvidia

Investors are advised to consider SPDR S&P 500 ETF Trust (SPY) call options as a strategic move amid rising Treasury yields and upcoming market catalysts, particularly Nvidia's earnings report, which could significantly influence market performance.

Analysts Ritholtz Wealth Management highlight Merck & Co., Inc. (MRK) and Amgen (AMGN) as biotech stocks show significant breakout potential

08/24/2026, 08:38 AM investing review Analysts: analysts, Ritholtz biotech Merck Amgen

Merck's recent Phase 3 trial success in combination therapy has significantly boosted its stock, indicating a positive shift in investor sentiment towards its pipeline. This development, along with Amgen's strong performance, highlights a broader resurgence in the biotech sector, which could attract more investor interest.